论文信息 - Safety and Immunogenicity of CpG 1018 and Aluminium Hydroxide-Adjuvanted SARS-CoV-2 S-2P Protein Vaccine MVC-COV1901: A Large-Scale Double-Blinded, Randomised, Placebo-Controlled Phase 2 Trial - 字舞流文

Safety and Immunogenicity of CpG 1018 and Aluminium Hydroxide-Adjuvanted SARS-CoV-2 S-2P Protein Vaccine MVC-COV1901: A Large-Scale Double-Blinded, Randomised, Placebo-Controlled Phase 2 Trial

W. Ko | Y.-H. Chen | S. Shih | C. Chen | S. Hsieh | W.-S. Lee | C. Chang | S. Hwang | J.-j. Liang | S. Cheng | C. Lien | K. Hwang | M. Liu | Y.-L. Lee | Y.-L. Lin | T. Lin | C.-G. Huang | Chien-Chun Liao | N.-C. Wang | I.-C. Tai